Filing Details
- Accession Number:
- 0001131096-14-000070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-24 14:54:12
- Reporting Period:
- 2014-12-22
- Filing Date:
- 2014-12-24
- Accepted Time:
- 2014-12-24 14:54:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131096 | Athenahealth Inc | ATHN | Services-Business Services, Nec (7389) | 043387530 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1210881 | Robert Cosinuke | C/O Athenahealth, Inc 311 Arsenal Street Watertown MA 02472 | Svp, Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-10-27 | 2,000 | $0.00 | 42,804 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2014-12-22 | 6,000 | $25.67 | 48,804 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-12-22 | 3,000 | $138.75 | 45,804 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-12-22 | 3,000 | $139.88 | 42,804 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-12-22 | 6,000 | $0.00 | 6,000 | $25.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,000 | 2010-01-05 | 2019-03-02 | No | 4 | M | Direct |
Footnotes
- Represents a bona fide gift.
- The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on October 21, 2014, in accordance with Rule 10b5-1
- This price represents the weighted average of sales ranging from $138.50 to $139.28. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average of sales ranging from $139.59 to $140.55. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.